Teleflex Incorporated (TBH.F)
| Previous close | 232.00 |
| Open | 236.00 |
| Bid | 234.00 x 10000 |
| Ask | 238.00 x 10000 |
| Day's range | 236.00 - 236.00 |
| 52-week range | 191.00 - 320.00 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 11.206B |
| Beta (5Y monthly) | 0.99 |
| PE ratio (TTM) | 29.06 |
| EPS (TTM) | 8.12 |
| Earnings date | 22 Feb 2023 - 27 Feb 2023 |
| Forward dividend & yield | 1.27 (0.55%) |
| Ex-dividend date | 14 Nov 2022 |
| 1y target est | 462.55 |
- GlobeNewswire
Standard Bariatrics, Inc., now part of Teleflex, Awarded Bariatric Stapling Technology Agreement with Premier Inc.
WAYNE, Pa., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded a group purchasing organization (GPO) agreement with Premier®, Inc. for the Titan SGS® powered stapling device, expanding access to this innovative technology for surgeons affiliated with Premier. The Titan SGS® device is a sterile, single patient use instrument used for longitudinal transection and resection of the gastric tissue for
- GlobeNewswire
Teleflex Launches National Ad Campaign — “Pit Stop” — to Raise Awareness of the UroLift® System as a Treatment for Enlarged Prostate
The campaign drives education about the importance of regular health screenings and treatment options for benign prostatic hyperplasia (BPH), a common men’s health condition.WAYNE, Pa., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the launch of a new national advertising campaign to raise awareness of the UroLift® System, the leading minimally invasive, outpatient treatment in the United States for enlarge
- Zacks
Will Teleflex (TFX) Beat Estimates Again in Its Next Earnings Report?
Teleflex (TFX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
